Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Levi & Korsinsky is investigating the Board of Directors of Poniard Pharmaceuticals, Inc. (“Poniard” or the “Company”) (NASDAQ: PARD) for possible breaches of fiduciary duty and...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Poniard Pharmaceuticals, Inc. (“Poniard” or the...
Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility PR Newswire SAN FRANCISCO, Dec. 21, 2010 SAN FRANCISCO, Dec. 21, 2010...
Poniard Pharmaceuticals Announces Plan for Voluntary Prepayment of Term Loan and Transfer to Nasdaq Capital Market PR Newswire SOUTH SAN FRANCISCO, Calif., Dec. 16, 2010 SOUTH SAN FRANCISCO...
Poniard Pharmaceuticals Reports Third Quarter 2010 Financial Results - Conference Call Today at 4:30 p.m. Eastern Time - PR Newswire SOUTH SAN FRANCISCO, Calif.,, Nov. 9, 2010 SOUTH SAN...
Poniard Pharmaceuticals Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program PR Newswire SOUTH SAN FRANCISCO, Calif., Nov. 4, 2010 SOUTH SAN FRANCISCO, Calif., Nov. 4...
Poniard Pharmaceuticals to Host Third Quarter 2010 Financial Results Conference Call PR Newswire SAN FRANCISCO, Nov. 3, 2010 SAN FRANCISCO, Nov. 3, 2010 /PRNewswire-FirstCall/ -- Poniard...
Poniard Pharmaceuticals Reports Second Quarter 2010 Financial Results - Conference Call Today at 4:30 p.m. Eastern Time - -Principal Accounting Officer Mike Jackson Named Interim CFO- PR...
Poniard Pharmaceuticals to Host Second Quarter 2010 Financial Results Conference Call PR Newswire SOUTH SAN FRANCISCO, Calif., Aug. 2 SOUTH SAN FRANCISCO, Calif., Aug. 2 /PRNewswire-FirstCall/...
Poniard Pharmaceuticals Receives NASDAQ Deficiency Notice Related to Minimum Bid Price PR Newswire SOUTH SAN FRANCISCO, Calif., July 22 SOUTH SAN FRANCISCO, Calif., July 22 /PRNewswire-FirstCall/...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
